hydrochlorothiazide has been researched along with Hyperhomocysteinemia in 2 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperhomocysteinemia is a risk factor for arterial diseases, and the deterioration of the arterial elastic structures is one of the possible mechanisms underlying this epidemiological association." | 5.30 | Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide. ( Augier, T; Bescond, A; Chareyre, C; Charpiot, P; Fraterno, M; Garçon, D; Rolland, PH, 1998) |
| "Hyperhomocysteinemia is a risk factor for arterial diseases, and the deterioration of the arterial elastic structures is one of the possible mechanisms underlying this epidemiological association." | 1.30 | Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide. ( Augier, T; Bescond, A; Chareyre, C; Charpiot, P; Fraterno, M; Garçon, D; Rolland, PH, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ntaios, G | 1 |
| Savopoulos, C | 1 |
| Chatzopoulos, S | 1 |
| Mikhailidis, D | 1 |
| Hatzitolios, A | 1 |
| Charpiot, P | 1 |
| Bescond, A | 1 |
| Augier, T | 1 |
| Chareyre, C | 1 |
| Fraterno, M | 1 |
| Rolland, PH | 1 |
| Garçon, D | 1 |
1 review available for hydrochlorothiazide and Hyperhomocysteinemia
| Article | Year |
|---|---|
Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: a systematic review and metaanalysis.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Clinical Trials as Topic; Fibric Acids; Homocys | 2011 |
1 other study available for hydrochlorothiazide and Hyperhomocysteinemia
| Article | Year |
|---|---|
Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide.
Topics: Animals; Antihypertensive Agents; Aorta, Abdominal; Captopril; Coronary Vessels; Disease Models, Ani | 1998 |